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Reconstruction of occluded thoracic duct for
treatment of chylopericardium: A novel surgical
therapy
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Peter Gloviczki, MD,b Rochester, Minn
Chylopericardium is an uncommon disease predominantly caused by trauma. Prolonged chyle depletion may result in
nutritional, metabolic, and immunologic deficiencies due to loss of essential proteins, immunoglobulins, fat, vitamins,
electrolytes, and water. Medical treatment includes a low-fat diet with medium-chain triglyceride restriction, cardiac
support, diuretic medications, and drainage of the pericardial effusion. Conventional surgical therapy consists of
pericardial fenestration and thoracic duct ligation. We report a case of massive secondary chylous pericardial effusion
successfully treated with microsurgical lymphovenous anastomosis, reconnecting the occluded thoracic duct to the
internal jugular vein. This case highlights features and management strategies of this perplexing clinical condition.
(J Vasc Surg 2008;48:1600-2.)Chylous pericardial effusion (chylopericardium) is a
rare clinical condition characterized by an accumulation of
triglyceride-rich lymphatic fluid in the pericardial cavity. It
is most commonly caused by malignant occlusion or trau-
matic disruption of the thoracic duct or by lymphatic injury
during mediastinal or cardiac interventions (secondary chy-
lopericardium).1-3 Lymphangiectasia and intrinsic thoracic
duct occlusion have been causes of primary chylopericar-
dium.1,2 Prolonged chyle depletion and pericardial effusion
may result in nutritional, metabolic, and immunologic
deficiencies due to loss of essential proteins, immunoglobu-
lins, fat, vitamins, electrolytes, and water, with a mortality
rate of up to 50%.4,5 The potential for cardiovascular he-
modynamic constraint from the pericardial effusion and the
morbidity associated with chronic loss of chyle make early
recognition and management essential.
The mainstay of treatment involves noninvasive mea-
sures to decrease chyle production and to drain the pericar-
dial fluid by pericardiocentesis. Medical treatment includes
a low-fat diet with medium-chain triglyceride restriction,
cardiac support, diuretic medications, and drainage of the
pericardial effusion. Current surgical treatment includes
fenestration of the pericardium and ligation of the thoracic
duct low in the chest with use of open or thoracoscopic
surgery.5,6 Reconstruction of the occluded thoracic duct in
a patient with isolated recurrent secondary chylopericar-
dium due to thoracic duct occlusion has not been previ-
ously reported, to our knowledge. In this article, we de-
scribe a case of massive chylous pericardial effusion
From the Division of Cardiovascular Diseasesa and the Division of Vascular
and Endovascular Surgery,b Mayo Clinic.
Competition of interest: none.
Reprint requests: Rowlens M. Melduni, MD, Division of Cardiovascular
Diseases, Mayo Clinic, 200 First St, SW, Rochester, MN 55905 (e-mail:
melduni.rowlens@mayo.edu).
0741-5214/$34.00
Copyright © 2008 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2008.06.066
1600successfully treated with thoracic duct–internal jugular vein
anastomosis.
CASE REPORT
A 74-year-old woman was referred to Mayo Clinic because of
4 months of persistent chylous pericardial effusion after a fall
against a table. The patient reported weight loss, weakness, fatigue,
chest discomfort, and dyspnea, which persisted for a month after
pericardiocentesis at a local hospital. At our institution, results of
physical examination were unremarkable. An echocardiogram
showed a large posterior pericardial effusion. Approximately
500 mL of pericardial fluid with a milky appearance was aspirated
through a pigtail catheter. Laboratory analysis was consistent with
a chylous effusion.
An extensive evaluation was undertaken to find the cause of
the chylous pericardial effusion. Computed tomographic scans of
the chest, abdomen, and pelvis showed no evidence of malignancy.
A lymphangiogram showed typical lymphatic drainage of the pelvis
and abdomen, but the distal thoracic duct was distended, and the
proximal thoracic duct immediately below the junction of the
subclavian and jugular veins was occluded. Numerous dilated
lymphatic collaterals were seen in the chest and mediastinum. A
venogram showed patent internal jugular and innominate veins
and a widely patent superior vena cava.
Initially, the patient was treated conservatively with drainage
of the pericardial space and restriction of dietary fat to medium-
chain fatty acids. Despite these measures, the daily output of
500 mL of chylous pericardial fluid persisted. We concluded from
our clinical investigations that the chylopericardium was due to
proximal thoracic duct occlusion with reflux of chyle into the
pericardium through lymphatic collaterals; therefore, we opted for
release of the thoracic duct occlusion to decrease reflux of chyle
into the pericardial space.
The patient was fed a high-fat meal of 60 g of butter with a
glass of whipped cream 4 hours before the operation to enhance
both chyle production and visualization of the thoracic duct. A
5-cm transverse incision was made just superior to the clavicle, and
the lateral head of the sternocleidomastoid muscle was transected.
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vein and the thoracic duct were dissected.
The thoracic duct was proximally occluded, but distally it was
patent, tortuous, and dilated to a diameter of 3 mm (Fig 1). The
patient received heparin. The internal jugular vein was cross-
clamped proximally and distally and opened longitudinally on its
posterior wall. With the use of an operating microscope, an end-
to-side anastomosis was performed between the duct and the vein
with interrupted 8-0 monofilament suture (Fig 2). To avoid injury
and ensure continuous chyle drainage, the thoracic duct was not
clamped during the anastomosis. After completion of the anasto-
mosis, chyle filled the clamped internal jugular vein segment well
(Fig 3). The wound was closed over a small drain.
The patient’s postoperative course was uneventful. In six
12-hour intervals after surgery, the amounts of pericardial catheter
drainage were 250, 112, 43, 17, 12, and 12 mL. A predismissal
echocardiogram showed no pericardial effusion. On postoperative
day 6, the pericardial catheter was removed, and the patient was
dismissed from the hospital. She was prescribed warfarin for 3
months for prevention of thrombosis and early occlusion of the
microvascular anastomosis, especially in the vein and at the suture
Fig 1. The obstructed thoracic duct is shown at its anchor point
with the left internal jugular vein.
Fig 2. The completed thoracic duct reanastomosis to left internal
jugular vein is shown.line. The restriction of her dietary fat was continued for 3 months.A postoperative follow-up echocardiogram at 4 months
showed only a small posterior pericardial effusion. The pericardial
effusion, as well as the patient’s symptoms, had completely re-
solved 3 months later.
DISCUSSION
We describe the first reported case, to our knowledge,
of a chylous pericardial effusion due to thoracic duct ob-
struction successfully treated with microsurgical recon-
struction of the occluded thoracic duct through an end-to-
side anastomosis between the thoracic duct and the left
internal jugular vein that left the pericardium intact. This
approach is most consistent with restoration of nearly nor-
mal physiology.
When the thoracic duct is obstructed at the level of the
ostium, reflux of chyle into the pericardium can occur
through collateral lymphatic channels or because of incom-
petence of the mediastinal lymphatic valves due to elevated
lymphatic pressure. Our patient most likely had intrinsic
disease of her lymphatic system with minimal reserve. The
fall against the table likely resulted in inflammation of the
lymphatic vessels and occlusion at the level of the thoracic
duct, with consequent development of symptomatic sec-
ondary chylous pericardial effusion. Therefore, treatment
of the obstruction that returns lymphatic flow to a relati-
vely normal systemmay cure the condition without need of
such additional invasive therapies as pericardiectomy or
pericardial window.
Nonetheless, although thoracic duct reconstruction re-
sults in substantial symptomatic improvement and volume
reduction, the condition may recur. Recurrence may result
because of a persistent defect of the ruptured lymphatics
with lymphopericardial or lymphothoracic fistula, especially
in patients with persistent lymphatic dilation and valvular
incompetence. Recurrence may also be due to technical
failure, causing stenosis, occlusion, or rupture of the duct.
Recurrences should be managed conservatively because it
may take some time before normal lymphatic flow is fully
Fig 3. Chyle filled the clamped internal jugular vein segment after
completion of anastomosis, which is covered by the distended vein.restored. In cases of prolonged time to recovery, a lym-
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leak, stenosis, or occlusion.
The optimal management of chylopericardium is not
well known because the condition is rare and no large
prospective studies or guidelines are available. In the ab-
sence of a history of direct trauma with temporal correla-
tion of the onset of symptoms, mediastinal malignancy
must be excluded. Conservative management aimed at
decreasing lymphatic output and decreasing chyle produc-
tion is the first stage of therapy, followed by intermittent
percutaneous drainage of the pericardial effusion and nu-
tritional support to replace the lipids and albumin lost in
the chyle. Open or thoracoscopic surgery is the next step.6
There is no standard approach to guide the duration of
conservative therapy before a surgical intervention is
planned.5,6 Patients who are draining500 mL of pericar-
dial fluid in the first 24 hours after cessation of oral intake
and the initiation of total parenteral nutrition tend to
improve with conservative management. By comparison,
patients from whom 1 L of fluid drains daily may benefit
from surgical intervention within 5 to 7 days.7 Prolonged
drainage of a chylopericardium should be avoided to pre-
vent immunosuppression and malnourishment,4 which
may limit the patient’s tolerance to definitive surgical ther-
apy.
Standard surgical treatment includes fenestration of the
pericardium to connect the pericardiac space with the
pleura and facilitate absorption of the fluid. In addition,
open or thoracoscopic ligation of the thoracic duct low in
the chest has been recommended to decrease chyle flow to
the upper chest and the mediastinum.8 Ligation of chylous
leaks and sites of lymphatic ruptures can also be attempted
after the patient has a meal with high fat content.9In our patient, we used a microsurgical lymphovenous
anastomosis to reconstruct the occluded thoracic duct at
the base of the neck and reestablish a nearly normal physi-
ology of lymphatic drainage, thereby successfully treating,
for the first time, chylopericardium with thoracic duct
reconstruction without the need for thoracic duct ligation
or pericardiectomy.
We acknowledge the following individuals who were
involved in the care of the patient for their helpful review
and commentary in preparation of this manuscript: Michael
D. McGoon, MD, and Manju Kalra, MBBS.
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